Source: Insider According to sources familiar with the matter, the cryptocurrency market structure bill could advance in mid-May.
BlockBeats News, May 1st. According to sources, the cryptocurrency market structure bill may advance in mid-May. This Wednesday, key figures involved in cryptocurrency legislation negotiations, including Republican Senator Thom Tillis of North Carolina, revealed that the Senate Banking Committee Chairman, Republican Senator Tim Scott of South Carolina, has been asked to "expedite scheduling" a hearing to revise and vote on the bill.
In addition, another negotiator this week, Angela Alsobrooks, mentioned that if lawmakers want a bipartisan vote in the Senate Banking Committee, they must address issues of illegal financing and ethics. However, Chairman Scott stated that he believes the ethics provision does not need to go through his committee's review. It is currently unclear where this provision will move next and whether it should be reviewed by other committees, but discussions are likely to take place before it is brought to a vote in the full Senate.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Crypto prices
More
